Skip to main navigation Skip to search Skip to main content

ACE Inhibitors as Countermeasures for Hematopoietic-Acute Radiation Syndrome

Project Details

Description

Investigation of captopril and other ACE inhibitors and Angiotensin Blockers for mitigation of hematopoietic acute radiation syndrome

Layman's description

This research investigates the use of captopril and related drugs for preventing bone marrow injury by radiation exposure.
StatusActive
Effective start/end date10/01/1029/04/28

Funding

  • Defense Medical Research & Development Program: $128,000.00
  • Defense Medical Research & Development Program: $1,112,000.00
  • Defense Threat Reduction Agency: $690,000.00
  • US Army Medical Research and Development Command: $797,000.00
  • Armed Forces Radiobiology Research Institute: $954,453.00

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.